7 unknown, 6 completed, 2 recruiting, 1 active not recruiting. 6 Phase 2, 6 Phase 3, 5 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 3, Unknown 2, Recruiting 1 |
| Phase 3 | 6 | Completed 3, Unknown 3 |
| Not applicable | 5 | Active not recruiting 1, Completed 1, Not yet recruiting 1, Recruiting 1, Unknown 1 |
Follow TP: new trials by email Literature Review of TP trials Research Report on TP
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ME/CFS Brain Fog: Cognitive Rehabilitation Trial Processing Speed Training, In-session Instrumental Activities of Daily Living Training, Transfer Package - ME/CFS, ME/CFS Following EBV-associated Infectious Mononucleosis | Not applicable | Recruiting | University of Alabama at Birmingham | 30 | 2026-06-23 | 2026-10-29 |
| Effect of Vitamin D and Branched-chain Amino Acids on Physical Performance and Biomarkers of Muscle Fatigue in Runners Training program, Branched-Chain Amino Acids, Vitamin D - Healthy Adult Male, Runners | Not applicable | Not yet recruiting | Pedro Julian Flores Moreno | 64 | 2026-01-01 | 2026-01-12 |
| Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma Paclitaxel and Cisplatin, Cadonilimab, Radiotherapy - Endometrial Neoplasms, Neoplasm Recurrence, Local | Phase 2 | Recruiting | Shandong Cancer Hospital and Institute | 30 | 2024-06-13 | 2026-04-24 |
| Long COVID Brain Fog: Cognitive Rehabilitation Trial Processing Speed Training, In-lab Instrumental Activities of Daily Living Training, In-lab Brain Health Training - Long COVID, Brain Fog | Not applicable | Active not recruiting | University of Alabama at Birmingham | 40 | 2024-04-25 | 2026-10-29 |
| Neoadjuvant Anti-PD-1 Immunotherapy With Chemotherapy in Resectable Locally Advanced Oral Squamous Cell Carcinoma Camrelizumab plus TP, TP - Oral Squamous Cell Carcinoma | Phase 3 | Unknown | Hospital of Stomatology, Wuhan University | 309 | 2023-11-21 | 2024-04-02 |
| Combination of Toripalimab and Chemoradiotherapy in Esophageal Cancer Toripalimab, Paclitaxel/Cisplatin, Intensity-modulated radiotherapy - Unresectable Esophageal Cancer | Phase 2 | Completed | Mian XI | 42 | 2019-06-25 | 2022-08-23 |
| Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer Toripalimab, Paclitaxel/cisplatin, Intensity-modulated radiotherapy - Esophageal Squamous Cell Carcinoma by AJCC V8 Stage, Resectable Esophageal Cancer | Phase 2 | Unknown | Jianhua Fu | 44 | 2019-06-25 | 2019-12-26 |
| Immunotherapy Combined With Chemoradiotherapy for First-line Treatment of Esophageal Squamous Cell Carcinoma（ChinECR） Immunotherapy, Chemotherapy drug, radiotherapy - ESCC | Not applicable | Unknown | Hebei Medical University Fourth Hospital | 800 | 2018-01-01 | 2025-06-03 |
| Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer Doxorubicin Hydrochloride Liposome Injection+carboplatin, paclitaxel +carboplatin - Ovarian Cancer | Phase 3 | Unknown | Hunan Cancer Hospital | 338 | 2017-08-01 | 2021-04-08 |
| Autologous Tumor Tissue Antigen-sensitized DC-CIK Cells Combined With Chemotherapy for Esophageal Cancer Paclitaxel, DC-CIK, Cisplatin - Esophageal Neoplasms, Neoplasms | Phase 2 | Unknown | Shenzhen Hornetcorn Bio-technology Company, LTD | 60 | 2015-12-01 | 2016-05-24 |
| A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer Paclitaxel and Cisplatin, Paclitaxel and Fluorouracil, Paclitaxel and Carboplatin - Stage III Esophageal Squamous Cell Carcinoma | Phase 3 | Completed | Fudan University | 321 | 2015-07-01 | 2022-02-09 |
| Neoadjuvant Chemotherapy Versus Surgery Alone for Esophageal Squamous Cell Carcinoma cisplatin and paclitaxel - Esophageal Neoplasm | Phase 3 | Completed | Henan Cancer Hospital | 528 | 2015-06-01 | 2022-10-05 |
| Intervention Effect of TP and AOB-w on Acrylamide Exposure in Chinese Adolescents Tea polyphenols, AOB-w, Placebo - Intervention | Not applicable | Completed | Zhejiang University | 110 | 2014-05-01 | 2017-05-17 |
| Preconditioning Chemotherapy Combination With Cytokine Induced Killer Cell (CIK) Immunotherapy Paclitaxel + Cisplatin, CIK cell therapy - Non Small Cell Lung Cancer | Unknown | Jinling Hospital, China | 100 | 2013-06-01 | 2013-07-18 | |
| GP VS TP in the Treatment of Advanced Nasopharyngeal Carcinoma in Northwest China gemcitabine and cisplatin, docetaxel and cisplatin - Nasopharyngeal Squamous Cell Carcinoma, Toxicity Due to Radiotherapy | Phase 2 | Completed | Air Force Military Medical University, China | 60 | 2012-05-01 | 2013-10-30 |
| A Multicenter Trial Evaluating the Efficacy of Nedaplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma nedaplatin and docetaxel, cisplatin and docetaxel - Nasopharyngeal Carcinoma | Phase 3 | Unknown | Guangxi Medical University | 2 | 2011-11-01 | 2011-11-28 |
| Docetaxel+Carboplatin vs Epirubicin+Cyclophosphamide Followed by Docetaxel as Adjuvant Treatment in Triple-negative Breast Cancer EC-T, TP - Breast Cancer | Phase 2 / Phase 3 | Completed | Chinese Academy of Medical Sciences | 320 | 2009-06-01 | 2021-02-09 |
Esophageal Squamous Cell Carcinoma (3) · Cognitive Dysfunction (2) · Esophageal Neoplasms (2) · Mental Fatigue (2) · Neoplasms (2) · Breast Neoplasms (1) · COVID-19 (1) · Carcinoma, Non-Small-Cell Lung (1) · Digestive System Neoplasms (1) · Endometrial Neoplasms (1) · Fatigue Syndrome, Chronic (1) · Nasopharyngeal Carcinoma (1) · Neoplasm Metastasis (1) · Neoplasm Recurrence, Local (1) · Ovarian Neoplasms (1)
University of Alabama at Birmingham (2) · Air Force Military Medical University, China (1) · Chinese Academy of Medical Sciences (1) · Fudan University (1) · Guangxi Medical University (1) · Hebei Medical University Fourth Hospital (1) · Henan Cancer Hospital (1) · Hospital of Stomatology, Wuhan University (1) · Hunan Cancer Hospital (1) · Jianhua Fu (1) · Jinling Hospital, China (1) · Mian XI (1) · Pedro Julian Flores Moreno (1) · Shandong Cancer Hospital and Institute (1) · Shenzhen Hornetcorn Bio-technology Company, LTD (1)
China (13) · United States (2) · Mexico (1)
Gitendra Uswatte, PhD (2) · Gang Chen, M.D. (1) · Jianhua Fu, MD (1) · Jing Wang, MD. (1) · Kuaile Zhao, MD (1) · Mei Shi, MD (1) · Pedro J Flores Moreno, Doctor of Medical Sciences (1) · Peng Xie (1) · Peng Yuan, MD (1) · Wenbin Shen, PhD (1) · Wu Fang, M.D. (1) · Yin Li, MD.&PhD. (1) · Zhiyuan Wang, Professor (1)
PMID 28317872, PMID 30344165, PMID 30642373, PMID 34648118, PMID 35188552, PMID 36861447, PMID 36990609, PMID 37560259, PMID 39235488, PMID 39281099, PMID 40791599